Log In
BCIQ
Print this Print this
 

ALT-801, TCR-IL-2

  Manage Alerts
Collapse Summary General Information
Company Altor BioScience Corp.
DescriptionSoluble tumor antigen-specific T cell receptor (TCR) linked to IL-2
Molecular Target p53
Mechanism of ActionCell therapy
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/04/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today